REVA to Present at Cowen and Company 38th Annual Health Care Conference
March 06, 2018 17:07 ET
|
REVA Medical Inc
SAN DIEGO, March 06, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that its Chief Financial Officer, Ms. Brandi Roberts, is scheduled to...
REVA to Hold Fourth Quarter and Full Year 2017 Financial Results Call
February 28, 2018 19:45 ET
|
REVA Medical Inc
SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) has scheduled a conference call to review its fourth quarter and full year 2017 financial results...
REVA Announces CE Mark and First Implant of the Fantom Encore Bioresorbable Scaffold
February 26, 2018 09:00 ET
|
REVA Medical Inc
SAN DIEGO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announces CE Mark of...
REVA Announces Appointment of Stephen Oesterle, MD to Board of Directors
February 05, 2018 09:00 ET
|
REVA Medical Inc
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announces the...
REVA Announces First Implant of the Fantom Bioresorbable Scaffold in Italy
January 24, 2018 17:56 ET
|
REVA Medical Inc
SAN DIEGO, Jan. 24, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced the first...
REVA to Present at 29th Annual Piper Jaffray Healthcare Conference
November 27, 2017 18:37 ET
|
REVA Medical Inc
SAN DIEGO, Nov. 27, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that its Chief Executive Officer, Ms. Reggie Groves, is scheduled to...
REVA Medical Reports Third Quarter 2017 Financial Results
November 07, 2017 16:15 ET
|
REVA Medical Inc
SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported...
REVA to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum
November 02, 2017 06:00 ET
|
REVA Medical Inc
SAN DIEGO, Nov. 02, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that its Chief Financial Officer, Ms. Brandi Roberts, is scheduled to...
REVA to Hold Third Quarter 2017 Financial Results Call
October 31, 2017 21:00 ET
|
REVA Medical Inc
SAN DIEGO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) has scheduled a conference call to review its third quarter 2017 financial results and provide a...
New Fantom Data Demonstrates Safety at 2 Years
October 31, 2017 20:04 ET
|
REVA Medical Inc
SAN DIEGO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- The Fantom bioresorbable scaffold from REVA Medical, Inc. (ASX:RVA) shows continued positive clinical outcomes according to an interim data set from the...